Avantor, a prominent global supplier of essential products and services to the life sciences and advanced technology sectors, has entered into a partnership with p-Chip Corporation to jointly develop a new line of “Smart Consumables.” This initiative will integrate p-Chip’s cutting-edge microtransponder technology into Avantor’s range of laboratory and clinical consumables. The collaboration brings together Avantor’s extensive industry experience and scale with p-Chip’s digital microtransponder platform. Together, they aim to work closely with strategic customers in life sciences, diagnostics, biomanufacturing, and healthcare to deliver solutions that support digital process control and ensure compliance with Chain-of-Identity requirements.
Health Technology Insights: Dermatology of Miami Adds Dr. George Glinos to Team
The Smart Consumables created through this partnership will offer a next-level solution for secure and reliable digital process control focused on Chain-of-Identity compliance. Laboratory items such as vials, slides, cassettes, tubes, and plates will feature a durable p-Chip microtransponder carrying a unique and secure identifier. This technology allows full traceability and automated control throughout the handling process, making certain that important samples and reagents are tracked and verified at every stage.
Health Technology Insights: Cohere Health Launches AI Prior Authorization Tool
With the rise of precision and personalized therapies, there is a growing necessity for accurate sample traceability and secure Chain-of-Identity processes. This is especially important in advanced therapies such as cell and gene treatments, where patient samples must be clearly and securely identified, continuously monitored, and linked to data throughout their lifecycle—from collection to treatment delivery. By embedding digital identification directly into lab consumables, these Smart Consumables provide the tracking, authenticity verification, and regulatory compliance needed to support these complex therapies.
Corey Walker, President of Laboratory Solutions at Avantor, explained that this innovation aligns with Avantor’s mission to foster scientific advancement while addressing important customer needs in fast-growing fields like personalized medicine. Walker stated that embedding digital technology into consumables will enhance traceability and process management, demonstrating Avantor’s dedication to creating proprietary, digitally advanced lab solutions. Michael Hadjisavas, Chief Operating Officer of Life Sciences and Healthcare at p-Chip Corporation, added that their microtransponder technology will be crucial in improving traceability and compliance within laboratory workflows. He highlighted that equipping consumables with secure digital IDs ensures an uninterrupted Chain-of-Identity for samples and reagents, which streamlines quality control and supports the ongoing digital transformation of pharmaceutical and healthcare processes, ultimately benefiting patient care in today’s digital healthcare landscape.
Health Technology Insights: LGC Group Opens New UK Labs to Boost Measurement Science
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
